TRPV4 and Hepatic fibrosis: Thus, TRPV4 may inhibit HSC apoptosis by regulating the activation of the autophagy-dependent AKT signaling pathway, and targeting TRPV4 may become an effective treatment strategy to prevent the progression of liver fibrosis.